Unverified record. The outcome below was inferred from the share-price reaction around this date. Nobody has confirmed it against an FDA, SEC or company document, and it may be wrong: we have published at least one inferred outcome that turned out to be impossible (see corrections). Treat it as a price observation, not as a regulatory fact. Verified decisions on this site always link a primary source.
Daily close, T-120 (9/10/25) through T+5. Run-up high $22.48 on 10/6/25, low $14.35 on 2/6/26 (T-120 to T-1). FDA decision 2/25/26. Historical price action, not a forecast.
Decision facts
FDA decision date2026-02-25
OutcomeUnconfirmed · price consistent with approval~ price-only (validating)
Decision-day move-3.4%
T-120 run-up (low→high)+4.0% ($14.35→$19.25)
ValidationOutcome consistent with price; primary-source verification in progress.